ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
about
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meetingHealth innovation in cardiovascular diseases.A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.Systematic procedure for the classification of proven and potential teratogens for use in research.The perils of protection: vulnerability and women in clinical research.
P2860
Q24193032-ACB2CDC6-DE1C-413F-81DE-4DF47846AB35Q30249670-7900CBA3-A1D2-4E3B-916C-8A5A12471540Q34999895-7814D2B1-8F05-4B61-AB34-0ABBC8BFEE1BQ35794981-88D2AA60-FD1F-4576-8DFC-EDB950FA9130Q36617472-B73CEE46-DDC5-4EF5-84FB-EDF16AB54928Q39060313-31BE9D5A-BD83-4926-8272-85201167A2F6Q40857819-D50C81E1-1813-4B9A-B0C8-AD00D2A6FFD8Q48240764-F7EBE374-02A2-4E31-9FC9-4D13215A1579
P2860
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@en
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@nl
type
label
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@en
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@nl
prefLabel
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@en
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@nl
P2860
P356
P1476
ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects.
@en
P2860
P304
P356
10.1002/BDRA.23043
P577
2012-07-11T00:00:00Z